EGFR antisense DNA is potential therapy for advanced head/neck tumors
Intrinsic subtype diagnosis accurately predicts breast cancer prognosis
Benefits of goserelin for early breast cancer persists long-term
Azacitidine ups survival in higher risk myelodysplastic syndromes
"Watch and wait" sometimes a viable option in mantle-cell lymphoma
Eltrombopag effective for treatment of thrombocytopenic purpura
Radiotherapy helpful when breast cancer is advanced at diagnosis
Biomarker, potential drug target identified for prostate cancer
Post-colectomy complications more frequent in obese patients
Combination surgery and radiotherapy benefits all women with DCIS
Cancer survivors often forgo needed care due to cost concerns
Breast cancer risk rapidly drops after stopping hormone therapy
Thalidomide may improve progression-free survival in prostate cancer